VTGN Competitors & Alternatives
Compare VistaGen Therapeutics Inc with similar stocks in the same industry
Biotechnology
VTGN
Main Stock$0.24
Tradestie Score
46
Market Cap
$108.92M
Revenue Growth
5.0%
Analyst Upside
+321.9%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.20
|
$114.01M | - | 44 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$32.00
|
$110.20M | - | 48 | Compare |
|
IRD
Opus Genetics, Inc. Common Stock
|
$6.04
|
$107.83M | - | 38 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 49 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$10.22
|
$71.32M | - | 43 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$12.14
|
$67.94M | - | 42 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$31.97
|
$62.81M | - | 39 | Compare |
|
OTLK
Outlook Therapeutics, Inc. Common Stock
|
$0.66
|
$46.20M | - | 61 | Compare |
|
TENX
Tenax Therapeutics, Inc.
|
$1.86
|
$34.77M | - | 39 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$3.90
|
$4.78M | - | 37 | Compare |
More VTGN Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
238 stocks in this industry